Generics 215

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Gliclazide manufacturers

215 products found

Filters

215 products found

gliclazide

Tablets 30mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
Switzerland
GMP approvals
EU GMP
Manufacturer #16196
The company is committed to providing and addressing healthcare needs as well as delivering patient care services across the globe. Through state of art facility, they have been working for more than 60 years and delivering nothing short of excellent.

Manufacturer usually replies in 10 days

gliclazide

Tablets, modified release (MR) 30 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
United Kingdom , Vietnam
Available for
Licensing with supply, Technology transfer
Comments
Ref: Diamicron LM (Servier)
Manufacturer #263
A pharmaceutical manufacturer based in the EU that has been active in 70+ countries selling its products all over the world for 40+ years. Key production lines are Rx, nutraceuticals, and medical devices. The company's production lines are GMP-compliant. The main dosage form is a solid oral dosage form.

Manufacturer usually replies in 9 days

gliclazide

Tablets, modified release (MR) 30 mg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
EU GMP
Comments
Dossier availability date: Q3-Q4 2024, VN as manufacturing site
Manufacturer #422

A pharmaceutical manufacturer based in the EU that has been active in 100+ countries selling its products in Europe, North America, Africa, the Middle East, and Asia for 40+ years. Main therapeutic areas include CNS, cardiovascular medication, and anti-infectives. The company's production lines are EU GMP-compliant. Key production lines are Rx and OTC. The company owns 20+ branches in Europe, Africa, and Asia.

Manufacturer usually replies in 5 days

gliclazide

Tablets, modified release (MR) 30mg, 60mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
Manufacturer #554

Manufacturer usually replies in 3 days

gliclazide

Tablets 80 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Canada
GMP approvals
Canada
Manufacturer #17783
It is a pharmaceutical company that began operations in the 2000s in North America and sells a wide selection of generic pharmaceuticals while continuing to expand its portfolio. They try to deliver accessible solutions for patient safety through continuing innovation such as simpler packaging and important safety features. They are laser-focused on developing cutting-edge solutions to ensure that patients have access to high-quality pharmaceuticals.

Manufacturer usually replies in 9 days

gliclazide

Tablets 40 mg, 160 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Manufacturer #21496

It's a fully integrated pharmaceutical corporation with a global reach. The company specializes in CMO and CDMO pharmaceutical preparations in a variety of dosage forms for a variety of therapeutic categories. GSK, Pfizer, Sanofi, Novartis, Mylan, Apotex, Adcock Ingram, and other MNCs manufacture formulations in various dosage forms for customers in 55 countries in important markets such as Europe, Australia & New Zealand, Canada, Japan, Far East Asia, GCC, Africa, LATAM, and CIS.

Manufacturer usually replies in 8 days

gliclazide

Tablets, modified release (MR) 30 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Unavailable markets
United Kingdom
Registered in
United Kingdom
Manufacturer #638

Manufacturer usually replies in 8 days

gliclazide

Tablets 80 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Malaysia
GMP approvals
EU GMP
Manufacturer #20853
The company’s mission is to invest in and operate businesses that restore health and enhances the lives of those they serve. Healthcare professionals use medicines and diagnostic devices to treat and manage infections, cardiovascular, metabolic, gastroenterological, rheumatic conditions, and more.

Manufacturer usually replies in 4 days

gliclazide

Tablets 80 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Malaysia
GMP approvals
EU GMP, PICS
Manufacturer #20652
It is a leading EU GMP-certified pharmaceutical company. It is focused on developing, manufacturing, and marketing branded off-patent pharmaceuticals, medical devices, and consumer healthcare products. The products are exported to countries in Asia Pacific, Africa, and the Middle East. Presence in over 22 countries. They have an experience of more than 50 years of in Southeast Asia.

Manufacturer usually replies in 5 days

gliclazide

Tablets, modified release (MR) 60mg, 90mg, 120mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Manufacturer #17488

Manufacturer usually replies in 2 days

gliclazide

Tablets 60mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
Thailand
GMP approvals
PICS
Manufacturer #14397
A pharmaceutical manufacturer based in Asia that has been active in Asia and the Middle East for 40+ years. The company's production lines are EU GMP-compliant. Key production lines are Rx, OTC, and nutraceuticals. The main therapeutic area includes the cardiovascular system, CNS, and anti-infec'tives.

Manufacturer usually replies in 3 days

gliclazide

Tablets 80 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Manufacturer #13225
It is an Indian manufacturer that is active in 40+ countries. They are in this line of business for 85+ years. The company has a more than $150 million turnover. The company manufactures and distributes more than 100 APIs and 200 formulations which is responsible for 25000+ SKUs. Quality control and quality assurance are one of the focus areas for the company.

Manufacturer usually replies in 3 days

gliclazide

Tablets, extended release (ER) 60 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Manufacturer #13225
It is an Indian manufacturer that is active in 40+ countries. They are in this line of business for 85+ years. The company has a more than $150 million turnover. The company manufactures and distributes more than 100 APIs and 200 formulations which is responsible for 25000+ SKUs. Quality control and quality assurance are one of the focus areas for the company.

Manufacturer usually replies in 3 days

gliclazide

Tablets 80 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO, India
Registered in
India
Available for
Licensing with supply, Distribution only
MAs for sale
India
Manufacturer #22627

Manufacturer usually replies in 4 days

gliclazide

Tablets 40 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Manufacturer #638

Manufacturer usually replies in 8 days

gliclazide

Tablets, modified release (MR) 30 mg, 60 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Malaysia
GMP approvals
FDA, WHO, PICS, MY, US
Unavailable markets
Brunei , Malaysia , Singapore , United States
Registered in
Malaysia
Available for
Licensing with supply, Distribution only, Technology transfer
Manufacturer #25654

Manufacturer usually replies in 2 days

gliclazide

Tablets 30 mg, 60 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
FDA
Comments
Reference Product : Diamicron® MR Tablets (Servier)
Manufacturer #18226

Manufacturer usually replies in 7 days

gliclazide

Tablets 40 mg, 80 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP, TGA
Manufacturer #18120

Manufacturer usually replies in 7 days

gliclazide

Tablets, modified release (MR) 60 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP, TGA
Manufacturer #18120

Manufacturer usually replies in 7 days

gliclazide + metformin hydrochloride

Tablets 80 mg + 500 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP, TGA
Manufacturer #18120

Manufacturer usually replies in 7 days

Want to view all 215 products? Create your free account today!

GLICLAZIDE

Gliclazide is an anti-diabetic medication for the treatment of diabetes mellitus type 2. Gliclazide controls hyperglycemia in gliclazide-responsive diabetes mellitus of stable, mild, non-ketosis prone, type 2 diabetes. As an oral antihyperglycemic agent, it is used for the treatment of non-insulin-dependent diabetes mellitus. It has been classified differently according to its drug properties based on its chemical structure. When launched it belonged to the first-generation of sulfonylurea due to the structural presence of a sulfonamide group able to release a proton and the presence of one aromatic group. However, further studies have shown that Gliclazide is a second-generation sulfonylurea, because it has higher potency and a shorter half-life. Gliclazide is sold under the brand names Diamicron, Diaprel, Azukon, and others. Gliclazide was first patented in 1966 and approved for medical use in 1972. Due to its efficacy and use around the world, it has been listed on the World Health Organization's List of Essential Medicines. Gliclazide is not available for sale in the United States.

Forms and dose:

Gliclazide is available as a tablet and extended-release tablet. In the treatment of type 2 diabetes, the total daily dose recommended varies from 40-320mg. The dose is increased or decreased depending on the response to the therapy. The initial adult dose starts with 40-80mg daily. This can be increased until adequate control is reached. Please note that any single dose should not exceed 160mg. if a patient feels that they need higher doses, it is recommended to take medicine twice a day instead.

The price of Gliclazide:

In India, the lowest price consumers can pay for an 80 mg pill is $0.33. The same supply can cost as low as USD64 for the same supply for medicine.

How does it work?

Gliclazide is in the sulfonylurea family of medications. Its actions increase the release of insulin. It binds to the β cell sulfonylurea receptor subsequently blocking the ATP sensitive potassium channels. The process leads to the closing of channels that leads to a resulting decrease in potassium efflux. This eventually leads to depolarization of the β cells. In the next step, it opens voltage-dependent calcium channels in the β cell resulting in activation of calmodulin. The result of this process is exocytosis of insulin-containing secretory granules.

Finding Gliclazide Manufacturers and Suppliers

The best way to find and gain access to Gliclazide manufacturers and Gliclazide suppliers is to use Pipelinepharma's global B2B online marketplace for medicines and other pharmaceuticals. Normally, finding trusted manufacturers and supplies of specific drugs like Gliclazide can be a time-consuming challenge, but with Pipelinepharma's simple search engine and network of proven partners, the whole process becomes a lot easier. All you need to do to get started is to make use of our integrated search engine and start looking for suppliers or manufacturers of Gliclazide to work with. You can fine-tune your search results using various filters too, letting you search for Gliclazide from specific countries, for example.